| Product Code: ETC7577061 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Indonesia therapeutic vaccines market, the import trend showed a decline, with a growth rate of -22.27% from 2023 to 2024 and a CAGR of -23.29% from 2020 to 2024. This downturn could be attributed to shifts in demand dynamics or changes in trade policies impacting market stability.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Therapeutic Vaccines Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Therapeutic Vaccines Market Revenues & Volume, 2022 & 2032F |
3.3 Indonesia Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Indonesia Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Indonesia Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Indonesia Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2022 & 2032F |
4 Indonesia Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Indonesia |
4.2.2 Rising government initiatives to promote vaccination programs |
4.2.3 Growing awareness about preventive healthcare measures |
4.3 Market Restraints |
4.3.1 High costs associated with therapeutic vaccines |
4.3.2 Limited access to healthcare facilities in remote areas of Indonesia |
4.3.3 Regulatory challenges in the approval process for new vaccines |
5 Indonesia Therapeutic Vaccines Market Trends |
6 Indonesia Therapeutic Vaccines Market, By Types |
6.1 Indonesia Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2022-2032F |
6.1.4 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2022-2032F |
6.1.5 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2022-2032F |
6.2 Indonesia Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2022-2032F |
6.2.3 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2022-2032F |
6.2.4 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2022-2032F |
6.2.5 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2022-2032F |
6.2.6 Indonesia Therapeutic Vaccines Market Revenues & Volume, By Others, 2022-2032F |
7 Indonesia Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Indonesia Therapeutic Vaccines Market Export to Major Countries |
7.2 Indonesia Therapeutic Vaccines Market Imports from Major Countries |
8 Indonesia Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of individuals vaccinated annually |
8.2 Rate of adoption of new therapeutic vaccines in Indonesia |
8.3 Level of government funding allocated to vaccination programs |
8.4 Percentage increase in healthcare facilities offering therapeutic vaccines |
8.5 Number of research and development projects focused on developing new vaccines in Indonesia |
9 Indonesia Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Indonesia Therapeutic Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Indonesia Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2022 & 2032F |
10 Indonesia Therapeutic Vaccines Market - Competitive Landscape |
10.1 Indonesia Therapeutic Vaccines Market Revenue Share, By Companies, 2025 |
10.2 Indonesia Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here